
Amy Jo Sterling
Examiner (ID: 4242, Phone: (571)272-6823 , Office: P/3631 )
| Most Active Art Unit | 3631 |
| Art Unit(s) | 3632, 3631 |
| Total Applications | 2801 |
| Issued Applications | 2050 |
| Pending Applications | 118 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6178594
[patent_doc_number] => 20020156246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => '15625 receptor, a novel G-protein coupled receptor'
[patent_app_type] => new
[patent_app_number] => 09/964008
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23644
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156246.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964008
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964008 | 15625 receptor, a novel G-protein coupled receptor | Sep 25, 2001 | Abandoned |
Array
(
[id] => 6625574
[patent_doc_number] => 20020086312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Screening assays for agonists and antagonists of receptor activator of NF-kappa B'
[patent_app_type] => new
[patent_app_number] => 09/957944
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18229
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086312.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957944 | Screening assays for agonists and antagonists of receptor activator of NF-κB | Sep 19, 2001 | Issued |
Array
(
[id] => 5846146
[patent_doc_number] => 20020132996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Secretory protein-48'
[patent_app_type] => new
[patent_app_number] => 09/955807
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34465
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955807
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955807 | Secretory protein-48 | Sep 18, 2001 | Abandoned |
Array
(
[id] => 1260391
[patent_doc_number] => 06663865
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Tumor necrosis factor antagonists and their use in endometriosis'
[patent_app_type] => B1
[patent_app_number] => 09/889828
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7127
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/663/06663865.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889828
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889828 | Tumor necrosis factor antagonists and their use in endometriosis | Sep 13, 2001 | Issued |
Array
(
[id] => 382970
[patent_doc_number] => 07306922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof'
[patent_app_type] => utility
[patent_app_number] => 10/380492
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7767
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380492 | Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof | Sep 11, 2001 | Issued |
| 09/936509 | Use of soluble tumor necrosis factor receptor for treatment heart failure | Sep 9, 2001 | Abandoned |
Array
(
[id] => 934045
[patent_doc_number] => 06977240
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-20
[patent_title] => 'Methods of using the OB receptor antibodies to treat bodyweight disorders'
[patent_app_type] => utility
[patent_app_number] => 09/950149
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 40
[patent_no_of_words] => 50620
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977240.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950149
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950149 | Methods of using the OB receptor antibodies to treat bodyweight disorders | Sep 9, 2001 | Issued |
Array
(
[id] => 1080948
[patent_doc_number] => 06835814
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Protease resistant flint analogs'
[patent_app_type] => B1
[patent_app_number] => 09/936019
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 20857
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936019
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936019 | Protease resistant flint analogs | Sep 6, 2001 | Issued |
Array
(
[id] => 650844
[patent_doc_number] => 07112421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/380703
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 40853
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112421.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380703 | Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto | Sep 5, 2001 | Issued |
Array
(
[id] => 6467370
[patent_doc_number] => 20020150977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'TNF receptor-like molecules and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/948018
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 45144
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 55
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150977.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948018
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948018 | Nucleic acids encoding MK61 receptors | Sep 4, 2001 | Issued |
Array
(
[id] => 6112571
[patent_doc_number] => 20020173463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/944944
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 69015
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944944 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Aug 30, 2001 | Issued |
Array
(
[id] => 517481
[patent_doc_number] => 07189566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'PRO347 nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 09/944896
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 68772
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189566.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944896 | PRO347 nucleic acids | Aug 30, 2001 | Issued |
Array
(
[id] => 6467354
[patent_doc_number] => 20020150976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/943851
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 69204
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150976.pdf
[firstpage_image] =>[orig_patent_app_number] => 09943851
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/943851 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Aug 29, 2001 | Abandoned |
Array
(
[id] => 6015865
[patent_doc_number] => 20020102647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/944449
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 65156
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102647.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944449 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Aug 29, 2001 | Abandoned |
Array
(
[id] => 6567332
[patent_doc_number] => 20020165143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/944403
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 69133
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165143.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944403
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944403 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Aug 29, 2001 | Abandoned |
Array
(
[id] => 6462436
[patent_doc_number] => 20020150583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Tumor necrosis factor receptors 6alpha & 6beta'
[patent_app_type] => new
[patent_app_number] => 09/935727
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 117695
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150583.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935727
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935727 | Tumor necrosis factor receptors 6α & 6β | Aug 23, 2001 | Issued |
Array
(
[id] => 6560307
[patent_doc_number] => 20020164690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Receptor based antagonists and methods of making and using'
[patent_app_type] => new
[patent_app_number] => 09/935868
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 164
[patent_figures_cnt] => 164
[patent_no_of_words] => 23901
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164690.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935868 | Receptor based antagonists and methods of making and using | Aug 22, 2001 | Abandoned |
Array
(
[id] => 5874586
[patent_doc_number] => 20020049160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'New strategy for drug design'
[patent_app_type] => new
[patent_app_number] => 09/934246
[patent_app_country] => US
[patent_app_date] => 2001-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6812
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049160.pdf
[firstpage_image] =>[orig_patent_app_number] => 09934246
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/934246 | New strategy for drug design | Aug 20, 2001 | Abandoned |
Array
(
[id] => 6362835
[patent_doc_number] => 20020058801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Mammalian alpha helical protein-1'
[patent_app_type] => new
[patent_app_number] => 09/932679
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14833
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058801.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932679 | Mammalian alpha helical protein-1 | Aug 15, 2001 | Abandoned |
| 09/928788 | Secreted proteins and uses thereof | Aug 12, 2001 | Abandoned |